NCT07621159 2026-06-02A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal CancerHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting120 enrolled